Showing results (101-110 of 679) with videos related to
Sort By:
Pageof 68
International Journal of Cancer|May 10, 2005
Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysisNathalie Rouas-Freiss, Sylvie Bruel, Catherine Menier, et al.Journal of Medical Economics|May 10, 2018
Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myelomaParameswaran Hari, Huamao Mark Lin, Yanyan Zhu, et al.Biology of Reproduction|April 9, 2005
HLA-G*0105N null allele encodes functional HLA-G isoformsMagali Le Discorde, Caroline Le Danff, Philippe Moreau, et al.Methods in Molecular Biology (Clifton, N.J.)|June 6, 2012
Simple methods for the detection of HLA-G variants in coding and non-coding regionsHolger Nückel, Erick C Castelli, Philippe Moreau, et al.Proceedings of the National Academy of Sciences of the United States of America|June 21, 2023
Speckle-correlation imaging through a kaleidoscopic multimode fiberDorian Bouchet, Antonio Miguel Caravaca-Aguirre, Guillaume Godefroy, et al.Cancer|June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 studyDavid J Vaughn, Sandy Srinivas, Walter M Stadler, et al.Haematologica|February 9, 2010
Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendationsBilal Mohty, Jean El-Cheikh, Ibrahim Yakoub-Agha, et al.Human Immunology|April 3, 2007
Hypoxia modulates HLA-G gene expression in tumor cellsGaël Mouillot, Céline Marcou, Inès Zidi, et al.Leukemia Research|September 5, 2007
CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosisRégis Bataille, Catherine Pellat-Deceunynck, Nelly Robillard, et al.Haematologica|March 4, 2008
Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphomaCaroline Bodet-Milin, Françoise Kraeber-Bodéré, Philippe Moreau, et al.Pageof 68